对抗类固醇ADEM的修改拉链方法:一个案例报告
Nihal Akçay1, İlyas Bingöl1, Hilal Merve Dolu2
1Department of Pediatric Intensive Care Unit, University of Health Sciences Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, 34303, Turkey.
Acta neurologica Belgica
|April 16, 2025
概括
一名儿童的抗类固醇急性扩散性脑膜炎 (ADEM) 通过修改的拉链技术得到改善,该技术结合了静脉注射免疫球蛋白 (IVIG) 和治疗性血交换 (TPE). 这种新的方法为挑战ADEM案件提供了一个有希望的替代方案.
科学领域:
- 儿科神经学 儿科神经学
- 神经免疫学 神经免疫学
- 炎症性脱叶林性疾病 炎症性脱叶林性疾病
背景情况:
- 急性扩散性脑膜炎 (ADEM) 是一种罕见的中枢神经系统炎症性疾病.
- 虽然通常对皮质类固醇有反应,但一些ADEM病例表现出类固醇耐药性,需要替代治疗.
研究的目的:
- 评估修改过的拉链技术的疗效,结合静脉注射免疫球蛋白 (IVIG) 和治疗性血交换 (TPE),在患有耐固醇ADEM的儿科患者中.
主要方法:
- 一名患有类固醇耐药ADEM的儿科患者接受了五个周期的交替TPE和IVIG (0.4g/kg/天).
- 使用TPE新鲜冷血,然后使用IVIG来增强免疫调节和抗体清除.
主要成果:
- 在两轮TPE治疗后,观察到显著的临床改善.
- 随访MRI显示白质病变明显回归.
- 患者在六个月后几乎完全康复,没有神经缺陷.
结论:
- 修改后的拉链技术 (TPE + IVIG) 是对抗类固醇ADEM的替代治疗方法.
- 需要进一步的受控研究来证实这种综合方法的有效性和安全性.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
105
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
105
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
87
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
87